Sinemet supply problems

MSD has warned that the availability of Sinemet (levodopa/carbidopa) will be reduced from late 2009 until 2011.

The global shortage of the Parkinson’s disease treatment, which is due to a change in supply source, will affect all presentations of Sinemet, Sinemet CR and Half Sinemet CR.

View Sinemet drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Close-up image of a COVID-19 antibody

Suspending methotrexate therapy shown to improve COVID booster response

Findings from a recent study showed that a two-week...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Sole of a foot with dry cracked skin on the heel.

New MIMS comparison table for urea-based emollients

Prescribers can now compare urea-based emollients with...